biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Money Threat

<< Previous

Bullboard Posts

Next >>

Comment by Cancundudeon May 11, 2022 10:18am

186 Views

Post# 34673749

RE:RE:RE:RE:RE:RE:RE:Money Threat

Let me give you an education dude! I am a non resident of Canada and not subjected to Canadian taxes and I am not eligible to benefits but ya nice try. Next time you come at me get educated on your argument before presenting it. And ya still living the dream. As far as my family, they are all doing well in Canada and living upto their responsibilities as Canadians. Congrats on BTI. Been a looong time coming and a looong way from its highs. Anyways glad your doing well

CCD.

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages